Provided by Tiger Trade Technology Pte. Ltd.

Verve Therapeutics

11.13
0.0000
Volume:- -
Turnover:114.94M
Market Cap:994.14M
PE:-5.30
High:11.13
Open:11.13
Low:11.13
Close:11.13
52wk High:11.41
52wk Low:2.86
Shares:89.32M
Float Shares:65.50M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1013
EPS(LYR):-2.3454
ROE:-34.26%
ROA:-19.35%
PB:2.10
PE(LYR):-4.75

Loading ...

Nov 07, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2022

Major Issues Report

8-K - Current report
Aug 09, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 21, 2022

Major Issues Report

8-K - Current report
Jul 21, 2022

Major Issues Report

8-K - Current report
Jul 20, 2022

Major Issues Report

8-K - Current report
Jul 12, 2022

Major Issues Report

8-K - Current report
Jul 08, 2022

Correspondence

CORRESP [Cover] - Correspondence
Jul 07, 2022

Major Issues Report

8-K - Current report
Jun 13, 2022

Major Issues Report

8-K - Current report
May 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 10, 2022

Major Issues Report

8-K - Current report
Mar 14, 2022

Major Issues Report

8-K - Current report
Mar 14, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 14, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals